Stock comparison
Corpay
Lam Research
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CPAY
Corpay
Market cap
$22.74B
Sector
Technology
LRCX
Lam Research
Market cap
$381.86B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CPAY | LRCX | Winner |
|---|---|---|---|
| Warren Buffett | 56C | 78B | LRCX |
| Benjamin Graham | 74B | 88A | LRCX |
| Philip Fisher | 56C | 76B | LRCX |
| Peter Lynch | 62C | 69B | LRCX |
| Joel Greenblatt | 28F | 84C | LRCX |
| Charlie Munger | 57D | 86A | LRCX |
| Terry Smith | 60D | 88A | LRCX |
Side-by-side metrics
| Metric | CPAY | LRCX |
|---|---|---|
| Market cap | $22.74B | $381.86B |
| P/E (TTM) | 18.8x | 55.4x |
| EV/EBIT | 11.8x | 62.9x |
| ROIC (TTM) | 9.16% | 42.79% |
| Gross margin | 72.79% | 49.98% |
| Net margin | 24.6% | 30.94% |
| Revenue CAGR 5y | 12.43% | 5.96% |
| EPS CAGR 5y | 10.5% | 11.27% |
| Debt / Equity | 3.0x | 0.4x |
| Dividend yield | 0.0% | 0.34% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CPAY leads on
- EV/EBIT11.8xvs 62.9x+81%
- P/E (TTM)18.8xvs 55.4x+66%
- Revenue CAGR 5y12.43%vs 5.96%+52%
- Gross margin72.79%vs 49.98%+31%
LRCX leads on
- Dividend yield0.34%vs 0.0%+100%
- Market cap$381.86Bvs $22.74B+94%
- Debt / Equity0.4xvs 3.0x+88%
- ROIC (TTM)42.79%vs 9.16%+79%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.